SIRT5 and glioblastoma: We found that downregulated SIRT5 expression was strongly correlated with a poorer patient prognosis, while a loss of SIRT5 function significantly enhanced GBM cell proliferation both in vitro and in vivo, possibly by disrupting mitochondrial signaling pathways.